Baldwin Brothers LLC Amgen Inc Transaction History

Baldwin Brothers LLC

  • $13.5 Billion
  • Q4 2024

A detailed history of Baldwin Brothers LLC transactions in Amgen Inc stock. As of the latest transaction made, Baldwin Brothers LLC holds 4,148 shares of AMGN stock, worth $1.14 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
4,148
Previous 5,430 23.61%
Holding current value
$1.14 Million
Previous $1.75 Million 38.19%
% of portfolio
0.01%
Previous 0.12%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 22, 2025
SELL
$258.78 - $328.31 $331,755 - $420,893
-1,282 Reduced 23.61%
4,148 $1.08 Million
Q3 2024

Oct 15, 2024
BUY
$309.38 - $337.38 $528,421 - $576,245
1,708 Added 45.89%
5,430 $1.75 Million
Q2 2024

Jul 12, 2024
SELL
$262.75 - $319.31 $31,792 - $38,636
-121 Reduced 3.15%
3,722 $1.16 Million
Q1 2024

Apr 12, 2024
SELL
$268.87 - $324.56 $64,797 - $78,218
-241 Reduced 5.9%
3,843 $1.09 Million
Q4 2023

Jan 08, 2024
SELL
$255.7 - $288.46 $12,273 - $13,846
-48 Reduced 1.16%
4,084 $1.18 Million
Q3 2023

Oct 10, 2023
SELL
$218.65 - $271.46 $11,151 - $13,844
-51 Reduced 1.22%
4,132 $1.11 Million
Q2 2023

Jul 14, 2023
SELL
$214.27 - $253.37 $80,136 - $94,760
-374 Reduced 8.21%
4,183 $928,000
Q4 2022

Jan 27, 2023
BUY
$229.03 - $291.01 $713,886 - $907,078
3,117 Added 216.46%
4,557 $0
Q3 2022

Oct 14, 2022
SELL
$224.46 - $253.15 $31,424 - $35,441
-140 Reduced 8.86%
1,440 $325,000
Q2 2022

Jul 18, 2022
SELL
$230.71 - $256.74 $145,347 - $161,746
-630 Reduced 28.51%
1,580 $384,000
Q1 2022

Apr 13, 2022
SELL
$219.27 - $242.57 $276,718 - $306,123
-1,262 Reduced 36.35%
2,210 $534,000
Q4 2021

Jan 14, 2022
BUY
$198.88 - $227.6 $68,016 - $77,839
342 Added 10.93%
3,472 $781,000
Q3 2021

Oct 27, 2021
SELL
$212.27 - $248.7 $2.8 Million - $3.28 Million
-13,197 Reduced 80.83%
3,130 $666,000
Q2 2021

Jul 30, 2021
SELL
$233.58 - $259.14 $9.45 Million - $10.5 Million
-40,466 Reduced 71.25%
16,327 $3.98 Million
Q1 2021

Apr 08, 2021
SELL
$221.91 - $258.6 $219,912 - $256,272
-991 Reduced 1.72%
56,793 $14.1 Million
Q4 2020

Jan 12, 2021
SELL
$216.38 - $257.67 $1.09 Million - $1.3 Million
-5,049 Reduced 8.04%
57,784 $13.3 Million
Q3 2020

Oct 16, 2020
SELL
$234.65 - $260.95 $215,878 - $240,074
-920 Reduced 1.44%
62,833 $16 Million
Q2 2020

Jul 21, 2020
BUY
$197.81 - $242.74 $36,199 - $44,421
183 Added 0.29%
63,753 $15 Million
Q1 2020

Apr 15, 2020
BUY
$182.24 - $241.7 $424,436 - $562,919
2,329 Added 3.8%
63,570 $12.9 Million
Q4 2019

Jan 29, 2020
SELL
$189.21 - $243.2 $118,256 - $152,000
-625 Reduced 1.01%
61,241 $14.8 Million
Q3 2019

Oct 10, 2019
SELL
$174.11 - $208.62 $728,998 - $873,491
-4,187 Reduced 6.34%
61,866 $12 Million
Q2 2019

Jul 19, 2019
SELL
$166.7 - $195.41 $340,234 - $398,831
-2,041 Reduced 3.0%
66,053 $12.2 Million
Q1 2019

Apr 24, 2019
SELL
$180.87 - $203.88 $666,867 - $751,705
-3,687 Reduced 5.14%
68,094 $12.9 Million
Q4 2018

Feb 01, 2019
BUY
$178.4 - $208.25 $61,726 - $72,054
346 Added 0.48%
71,781 $14 Million
Q3 2018

Oct 26, 2018
BUY
$185.29 - $208.89 $1.01 Million - $1.14 Million
5,464 Added 8.28%
71,435 $14.8 Million
Q2 2018

Jul 24, 2018
BUY
$166.05 - $186.51 $48,652 - $54,647
293 Added 0.45%
65,971 $12.2 Million
Q1 2018

Apr 16, 2018
SELL
$169.43 - $198.0 $1.71 Million - $2 Million
-10,076 Reduced 13.3%
65,678 $11.2 Million
Q4 2017

Jan 24, 2018
BUY
$168.79 - $188.59 $75,449 - $84,299
447 Added 0.59%
75,754 $13.2 Million
Q3 2017

Oct 26, 2017
BUY
$167.29 - $191.0 $12.6 Million - $14.4 Million
75,307
75,307 $14 Million

Others Institutions Holding AMGN

# of Institutions
3,080
Shares Held
404M
Call Options Held
7.56M
Put Options Held
7.16M
View Full List

About AMGEN INC

AMGN Quotes by TradingView
  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $147B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Baldwin Brothers LLC Portfolio

Follow Baldwin Brothers LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Baldwin Brothers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Baldwin Brothers LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email